Search Results 1-10 of 946 for %EC%98%81%EC%A3%BC%EC%BA%A1%ED%8B%B4%EA%B0%80%EA%B2%A9%EF%BC%88TALK:ZA32%EF%BC%8924%EC%8B%9C%EA%B0%84%20%EC%BD%9C%EC%84%BC%ED%84%B0%ED%9C%B424%EC%8B%9C%20%EC%A0%95%ED%86%B5%EC%A7%80%EC%95%95%EC%9B%90

  1. ... EA ADD HR,162 260000007,HC IV INF THER INIT 1ST HR,369 260000008,HC IV PUSH EA ADD SEQ DRUG,171 260000009,HC IV PUSH EA ADD SEQ NEW DRUG,140 260000010,HC ...

  2. ... EA ADD HR,177,187.00, 260000007,HC IV INF THER INIT 1ST HR,454,482.00, 260000008,HC IV PUSH EA ADD SEQ DRUG,180,185.00, 260000009,HC IV PUSH EA ADD SEQ NEW ...

  3. ... EA ADD HR,125,150, 260000007,HC IV INF THER INIT 1ST HR,400,460, 260000008,HC IV PUSH EA ADD SEQ DRUG,108,143, 260000009,HC IV PUSH EA ADD SEQ NEW DRUG ...

  4. Twitter - Tushar Patel.

  5. ... B vaccine 20 mcg/0.5 mL-adjuvant CpG 1018 (PF) IM syringe,173.6 636000003,43528000305,hepatitis B vaccine 20 mcg/0.5 mL-adjuvant CpG 1018 (PF) IM syringe ...

  6. A Study to Follow Durability of Patient Responses from Studies UT001 and TC-BC-12 - Mayo Clinic

    The purposes of this study are to determine the durability of response in patients with low grade upper tract urothelial carcinoma (LG-UTUC) treated with ...

  7. ... 8 unit-32 unit/0.5 mL injection suspension,35.4 ... B virus vaccine recomb (PF) 40 mcg/mL ... 20 mcg/0.5 mL-adjuvant CpG 1018 (PF) IM syringe ...

  8. A Study to Evaluate Rectal Cancer with Diffusion-Weighted and Dynamic Contrast Enhanced Perfusion-Weighted Magnetic Resonance Imaging - Mayo Clinic

    The purpose of this study is to analyze the apparent diffusion coefficient (ADC) from Diffusion-Weighted (DWI) in patients before, during the second week of and ...

  9. A Study to Investigate Intravenous Tocilizumab in Patients with Moderate-to-Severe COVID-19 Pneumonia (enrolling by invitation only) - Mayo Clinic

    The purpose of this study is assess the pharmacodynamics, pharmacokinetics, safety and effectiveness of two different doses of Tocilizumab (TCZ) in combination ...

  10. Stress Echo 2030 - Mayo Clinic

    This study (SE2030) will establish a platform of data to build the perfect stress echo test, suitable for all patients, anywhere, anytime, also quantitative and ...